KLRK1 and B-cell chronic lymphocytic leukemia: Even the decrease in NKG2D expression on CLL-derived NK cells has been found more marked in patients with advanced and progressive disease, suggesting that CLL cells may play a role in downregulating NKG2D expression [162].